United StatesÚltimas notícias

Hogan Lovells Head of Private Equity APAC Siew Kam Boon discusses how tensions in the Middle East will affect deal-making and the private equity market. She speaks with Haslinda Amin on "Insight with Haslinda Amin."

ESAI Energy Founder & President Sarah Emerson quantifies the impact of a three-week loss of crude oil exports through the Strait of Hormuz. Asia will be the focus of managing the oil market disruption due to its heavy reliance on imported crude. She speaks with Haslinda Amin on "Insight with Haslinda Amin."

Sylvia Sheng of JPMorgan Asset Management says Asian markets are seeing "a de-risking event happening" in light of the ongoing conflict in the Middle East.

Oil prices have jumped above $100 a barrel as major Middle East producers curbed production and the Strait of Hormuz remained all but closed. Bloomberg's Stephen Stapczynski discusses the outlook for energy markets.

Oil smashed through $100 a barrel as more major Middle East producers curbed production, the Strait of Hormuz remained all but closed and the US threatened to deepen a conflict that has upended energy markets. Bloomberg's Nicholas Lua has the latest.

Hewlett Packard Enterprise (NYSE:HPE) reported third-quarter financial results that showcased a significant acceleration in top-line growth, fueled by robust demand for its "as-a-service" offerings and high-performance computing.

Yext (NYSE:YEXT), the New York-based software developer specializing in digital presence and search, reported a net income of $4.2 million for its fiscal fourth quarter on Monday.

Anthropic PBC filed two federal lawsuits Monday challenging the Pentagon’s decision to label the artificial intelligence startup a “supply chain risk,” an unprecedented move following the company’s refusal to permit unrestricted military use of its Claude chatbot.

Precision BioSciences (NASDAQ:DTIL) shares are in focus after the U.S. Food and Drug Administration granted Fast Track designation to PBGENE-DMD, an investigational in vivo gene editing therapy designed to treat Duchenne muscular dystrophy (DMD).

Boundless Bio (NASDAQ:BOLD) reported a narrowed net loss for the full year 2025 and a strategic realignment of its oncology pipeline, prioritizing a novel kinesin degrader as it prepares to enter the next phase of clinical development.

Hims & Hers Health (NYSE:HIMS) shares surged as much as 52% in early trading Monday after the telehealth leader announced a surprising end to its legal battle with Novo Nordisk.

Alexander’s (NYSE:ALX) on Monday announced it has entered into an agreement to sell its Rego Park I property in Queens, New York, to Northwell Health for a gross purchase price of $235.5 million.